Abstract
BackgroundInflammatory myopathies (IMs) are systemic autoimmune diseases, characterized by reduced muscle strength and endurance. Although IMs are relatively rare, patients' disabilities in daily life are substantial. Thus, there is a...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
